Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T12:56:19.228Z.
Calculation as of: 2026-10-06T12:56:19.228Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7917a7cc8c7b4e75475caf5d3db61bffcb49ffeef440a300017a50834728fbad
PE RATIO
N/A
PE RATIO AVG TTM
42.65
PE RATIO AVG 3Y
42.65
PE RATIO AVG 5Y
42.65
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$8.78B
PE Ratio
N/A
TTM Avg
41.90
3Y Avg
41.90
5Y Avg
41.90
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytokinetics, Incorporated (CYTK) | $7.80B | N/A | 42.65 | 42.65 | 42.65 |
| HealthEquity, Inc. (HQY)vs › | $7.65B | 33.05 | 39.94 | 105.96 | 402.80 |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 76.44 | 71.10 | 44.44 | 44.44 |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.23B | N/A | 66.44 | 48.18 | 92.91 |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | 23.16 | 22.16 | 45.57 | 45.57 |
| Alkermes plc (ALKS)vs › | $7.17B | 111.64 | 44.92 | 25.77 | 27.28 |
| Caris Life Sciences, Inc. (CAI)vs › | $8.59B | 84.91 | 73.85 | 73.85 | 73.85 |
| Immunovant, Inc. (IMVT)vs › | $6.86B | N/A | N/A | N/A | N/A |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | N/A | 41.90 | 41.90 | 41.90 |
| Chemed Corporation (CHE)vs › | $6.68B | 25.67 | 23.86 | 27.91 | 28.44 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$62.70
Forward EPS (Est.)
$-6.05
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2017-05-04 | 52.50 |
| 2017-05-03 | 52.33 |
| 2017-05-02 | 52.00 |
| 2017-05-01 | 51.33 |
| 2017-04-28 | 54.67 |
| 2017-04-27 | 56.67 |
| 2017-04-26 | 56.33 |
| 2017-04-25 | 53.17 |
| 2017-04-24 | 51.83 |
| 2017-04-21 | 47.50 |
| 2017-04-20 | 45.17 |
| 2017-04-19 | 43.93 |
| 2017-04-18 | 43.17 |
| 2017-04-17 | 39.17 |
| 2017-04-13 | 38.67 |
| 2017-04-12 | 39.00 |
| 2017-04-11 | 38.00 |
| 2017-04-10 | 37.67 |
| 2017-04-07 | 38.10 |
| 2017-04-06 | 38.17 |
| 2017-04-05 | 37.33 |
| 2017-04-04 | 39.33 |
| 2017-04-03 | 41.50 |
| 2017-03-31 | 42.83 |
| 2017-03-30 | 42.67 |
| 2017-03-29 | 41.83 |
| 2017-03-28 | 41.67 |
| 2017-03-27 | 42.33 |
| 2017-03-24 | 42.00 |
| 2017-03-23 | 41.83 |
| 2017-03-22 | 42.67 |
| 2017-03-21 | 40.67 |
| 2017-03-20 | 41.67 |
| 2017-03-17 | 41.33 |
| 2017-03-16 | 44.50 |
| 2017-03-15 | 45.50 |
| 2017-03-14 | 43.33 |
| 2017-03-13 | 43.33 |
| 2017-03-10 | 43.33 |
| 2017-03-09 | 43.00 |
| 2017-03-08 | 41.17 |
| 2017-03-07 | 38.33 |
| 2010-08-04 | 5.93 |
| 2010-08-03 | 6.27 |
| 2010-08-02 | 6.16 |
| 2010-07-30 | 6.16 |
| 2010-07-29 | 6.07 |
| 2010-07-28 | 6.00 |
| 2010-07-27 | 6.18 |
| 2010-07-26 | 6.18 |
| 2010-07-23 | 5.73 |
| 2010-07-22 | 5.17 |
| 2010-07-21 | 4.97 |
| 2010-07-20 | 4.93 |
| 2010-07-19 | 4.97 |
| 2010-07-16 | 5.08 |
| 2010-07-15 | 5.46 |
| 2010-07-14 | 5.55 |
| 2010-07-13 | 5.66 |
| 2010-07-12 | 5.49 |
| 2010-07-09 | 5.57 |
| 2010-07-08 | 5.40 |
| 2010-07-07 | 5.19 |
| 2010-07-06 | 5.04 |
| 2010-07-02 | 5.10 |
| 2010-07-01 | 5.19 |
| 2010-06-30 | 5.31 |
| 2010-06-29 | 5.71 |
| 2010-06-28 | 5.98 |
| 2010-06-25 | 6.13 |
| 2010-06-24 | 5.80 |
| 2010-06-23 | 5.80 |
| 2010-06-22 | 5.84 |
| 2010-06-21 | 6.11 |
| 2010-06-18 | 6.27 |
| 2010-06-17 | 6.36 |
| 2010-06-16 | 6.38 |
| 2010-06-15 | 6.54 |
| 2010-06-14 | 6.16 |
| 2010-06-11 | 6.22 |
| 2010-06-10 | 6.20 |
| 2010-06-09 | 5.84 |
| 2010-06-08 | 5.96 |
| 2010-06-07 | 5.98 |
| 2010-06-04 | 6.27 |
| 2010-06-03 | 6.69 |
| 2010-06-02 | 6.47 |
| 2010-06-01 | 6.27 |
| 2010-05-28 | 6.58 |
| 2010-05-27 | 6.72 |
| 2010-05-26 | 6.43 |
| 2010-05-25 | 6.36 |
| 2010-05-24 | 6.36 |
| 2010-05-21 | 6.18 |
| 2010-05-20 | 6.29 |
| 2010-05-19 | 6.63 |
| 2010-05-18 | 6.69 |
| 2010-05-17 | 6.76 |
| 2010-05-14 | 6.65 |
| 2010-05-13 | 6.83 |
| 2010-05-12 | 6.76 |
| 2010-05-11 | 6.63 |
| 2010-05-10 | 6.69 |
| 2010-05-07 | 6.66 |
| 2010-05-06 | 6.80 |
| 2010-05-05 | 6.87 |
| 2010-05-04 | 7.12 |
| 2010-05-03 | 7.56 |
| 2010-04-30 | 7.37 |
| 2010-04-29 | 7.26 |
| 2010-04-28 | 7.33 |
| 2010-04-27 | 7.24 |
| 2010-04-26 | 7.28 |
| 2010-04-23 | 7.33 |
| 2010-04-22 | 7.37 |
| 2010-04-21 | 7.35 |
| 2010-04-20 | 7.44 |
| 2010-04-19 | 7.42 |
| 2010-04-16 | 7.56 |
| 2010-04-15 | 7.76 |
| 2010-04-14 | 8.15 |
| 2010-04-13 | 7.67 |
| 2010-04-12 | 7.85 |
| 2010-04-09 | 7.99 |
| 2010-04-08 | 8.08 |
| 2010-04-07 | 8.02 |
| 2010-04-06 | 7.79 |
| 2010-04-05 | 7.44 |
| 2010-04-01 | 7.33 |
| 2010-03-31 | 7.33 |
| 2010-03-30 | 7.42 |
| 2010-03-29 | 7.69 |
| 2010-03-26 | 7.83 |
| 2010-03-25 | 7.69 |
| 2010-03-24 | 7.95 |
| 2010-03-23 | 7.99 |
| 2010-03-22 | 7.76 |
| 2010-03-19 | 7.56 |
| 2010-03-18 | 7.60 |
| 2010-03-17 | 7.28 |
| 2010-03-16 | 7.56 |
| 2010-03-15 | 7.49 |
| 2010-03-12 | 7.72 |
| 2010-03-11 | 7.84 |
| 2010-03-10 | 7.84 |
| 2010-03-09 | 7.77 |
| 2010-03-08 | 7.91 |
| 2010-03-05 | 7.89 |
| 2010-03-04 | 7.73 |
| 2010-03-03 | 7.56 |
| 2010-03-02 | 7.40 |
| 2010-03-01 | 7.28 |
| 2010-02-26 | 7.10 |
| 2010-02-25 | 7.35 |
| 2010-02-24 | 7.19 |
| 2010-02-23 | 7.24 |
| 2010-02-22 | 7.28 |
| 2010-02-19 | 7.26 |
| 2010-02-18 | 7.35 |
| 2010-02-17 | 7.35 |
| 2010-02-16 | 7.31 |
| 2010-02-12 | 7.19 |
| 2010-02-11 | 7.07 |
| 2010-02-10 | 6.91 |
| 2010-02-09 | 7.05 |
| 2010-02-08 | 7.14 |
| 2010-02-05 | 7.03 |
| 2010-02-04 | 7.26 |
| 2010-02-03 | 6.98 |
| 2010-02-02 | 7.26 |
| 2010-02-01 | 7.10 |
| 2010-01-29 | 7.05 |
| 2010-01-28 | 6.82 |
| 2010-01-27 | 6.96 |
| 2010-01-26 | 6.91 |
| 2010-01-25 | 7.07 |
| 2010-01-22 | 7.03 |
| 2010-01-21 | 7.14 |
| 2010-01-20 | 7.03 |
| 2010-01-19 | 7.63 |
| 2010-01-15 | 7.75 |
| 2010-01-14 | 8.26 |
| 2010-01-13 | 7.91 |
| 2010-01-12 | 7.61 |
| 2010-01-11 | 8.05 |
| 2010-01-08 | 7.77 |
| 2010-01-07 | 7.28 |
| 2010-01-06 | 7.21 |
| 2010-01-05 | 7.33 |
| 2010-01-04 | 7.26 |
| 2009-12-31 | 6.79 |
| 2009-12-30 | 6.65 |
| 2009-12-29 | 6.51 |
| 2009-12-28 | 6.56 |
| 2009-12-24 | 6.63 |
| 2009-12-23 | 6.77 |
| 2009-12-22 | 6.65 |
| 2009-12-21 | 6.05 |
| 2009-12-18 | 6.16 |
| 2009-12-17 | 6.63 |
| 2009-12-16 | 7.00 |
| 2009-12-15 | 7.03 |
| 2009-12-14 | 7.14 |
| 2009-12-11 | 7.14 |
| 2009-12-10 | 6.98 |
| 2009-12-09 | 7.31 |
| 2009-12-08 | 7.14 |
| 2009-12-07 | 7.61 |
| 2009-12-04 | 7.59 |
| 2009-12-03 | 7.45 |
| 2009-12-02 | 7.33 |
| 2009-12-01 | 7.33 |
| 2009-11-30 | 7.24 |
| 2009-11-27 | 7.59 |
| 2009-11-25 | 7.82 |
| 2009-11-24 | 7.96 |
| 2009-11-23 | 8.12 |
| 2009-11-20 | 7.94 |
| 2009-11-19 | 8.05 |
| 2009-11-18 | 8.40 |
| 2009-11-17 | 8.08 |
| 2009-11-16 | 7.94 |
| 2009-11-13 | 7.82 |
| 2009-11-12 | 7.73 |
| 2009-11-11 | 7.61 |
| 2009-11-10 | 7.35 |
| 2009-11-09 | 7.66 |
| 2009-11-06 | 7.63 |
| 2009-11-05 | 14.17 |
| 2009-11-04 | 13.96 |
| 2009-11-03 | 13.96 |
| 2009-11-02 | 12.77 |
| 2009-10-30 | 13.57 |
| 2009-10-29 | 14.81 |
| 2009-10-28 | 18.17 |
| 2009-10-27 | 18.68 |
| 2009-10-26 | 18.89 |
| 2009-10-23 | 19.45 |
| 2009-10-22 | 20.43 |
| 2009-10-21 | 20.34 |
| 2009-10-20 | 20.89 |
| 2009-10-19 | 21.06 |
| 2009-10-16 | 21.83 |
| 2009-10-15 | 22.30 |
| 2009-10-14 | 21.57 |
| 2009-10-13 | 21.40 |
| 2009-10-12 | 21.79 |
| 2009-10-09 | 21.70 |
| 2009-10-08 | 20.81 |
| 2009-10-07 | 20.43 |
| 2009-10-06 | 20.17 |
| 2009-10-05 | 20.89 |
| 2009-10-02 | 20.64 |
| 2009-10-01 | 20.68 |
| 2009-09-30 | 22.51 |
| 2009-09-29 | 22.55 |
| 2009-09-28 | 22.04 |
| 2009-09-25 | 21.19 |
| 2009-09-24 | 19.06 |
| 2009-09-23 | 19.62 |
Showing the most recent 260 of 292 data points. The chart above shows the full history.
